BUY VIAGRON 100 (SILDENAFIL CITRATE) (100 MG/TAB. – 10 TABS)
MAIN PRODUCT DESCRIPTION
Product Overview
ViagrON 100 is an oral tablet containing sildenafil citrate, a medicine belonging to the phosphodiesterase type-5 (PDE-5) inhibitor class. According to the supplied information, it is used for the treatment of erectile dysfunction (ED), also commonly referred to as impotence.
Erectile dysfunction describes difficulty achieving or maintaining an erection adequate for sexual activity. Sildenafil works on the physiological mechanisms involved in erection by enhancing blood flow to erectile tissue when sexual stimulation is present.
The supplied product presentation identifies ViagrON 100 as a 100 mg sildenafil tablet supplied in a pack of 10 tablets. The source lists Hilma Biocare as the company.
Product Specifications
- Product: ViagrON 100
- Active Ingredient: Sildenafil citrate
- Stated Strength: 100 mg sildenafil
- Dosage Form: Tablet
- Route: Oral
- Pack Size: 10 tablets
- Pharmacological Class: PDE-5 inhibitor
- Molecular Formula supplied: C28H38N6O11S
- Molecular Weight supplied: 666.703 g/mol
- CAS Number supplied: 17159983-0
- Market Status: Prescription
- Company: Hilma Biocare
How Sildenafil Works
Sildenafil inhibits phosphodiesterase type 5, an enzyme involved in the breakdown of cyclic guanosine monophosphate (cGMP).
During sexual stimulation, nitric oxide is released in penile tissue. This increases cGMP, which contributes to relaxation of smooth muscle and dilation of blood vessels. The resulting increase in blood flow to the corpus cavernosum supports the development and maintenance of an erection.
By inhibiting PDE-5, sildenafil allows cGMP activity to continue for longer.
Importantly, sildenafil does not normally produce an erection without sexual stimulation. The supplied information specifically states that ViagrON works only when a person is sexually excited and that it does not increase sexual desire.
Erectile Dysfunction
The supplied information identifies ViagrON for the treatment of erectile dysfunction in men.
ED can have a range of underlying causes, including cardiovascular, metabolic, neurological, psychological and medication-related factors. Sildenafil acts on the erectile response but does not necessarily address the underlying cause of ED.
Men experiencing persistent erectile difficulties should discuss the condition with a qualified healthcare professional, particularly because ED can sometimes be associated with underlying cardiovascular or metabolic disease.
Onset of Action
According to the supplied information, ViagrON generally begins to work within approximately 30–60 minutes. The source states that the tablet may be taken up to several hours before anticipated sexual activity.
Food can influence the timing of sildenafil activity. In particular, the supplied information states that taking ViagrON after a heavy or high-fat meal may delay the onset of action.
Patients should follow the instructions provided by their healthcare professional and the official product information applicable to the specific presentation.
Administration
The supplied information recommends swallowing the tablet whole with a full glass of water and taking it approximately one hour before intended sexual activity.
The source states that ViagrON should not be taken more than once per day.
Because the supplied product contains 100 mg sildenafil, which represents a high tablet strength, the appropriate dose should be determined by a qualified healthcare professional. The stated strength should not be interpreted as an instruction for every patient to take 100 mg.
Cardiovascular Safety
One of the most important precautions with sildenafil concerns its interaction with nitrate medicines.
ViagrON should not be taken with nitrate-containing medicines used for angina or certain cardiovascular conditions. Sildenafil can significantly enhance the blood-pressure-lowering effects of nitrates, potentially resulting in a dangerous decrease in blood pressure.
The supplied information also identifies cardiovascular conditions in which sexual activity may be inadvisable. Patients with significant heart or blood-vessel disease should therefore obtain medical advice before using sildenafil.
Other Important Contraindications
The supplied product information lists the following circumstances in which ViagrON should not be used:
- Use of nitrate medicines for angina or other heart conditions
- Use of amyl nitrite
- Cardiovascular conditions making sexual intercourse inadvisable
- Recent heart attack or stroke
- Severe liver disease
- Unusually high or low blood pressure that is not adequately controlled
- Previous loss of vision associated with NAION
- Retinitis pigmentosa
- Known allergy to sildenafil or its ingredients
The source also advises caution in people with diabetes, kidney or liver problems, certain blood disorders, penile abnormalities, bleeding disorders, stomach ulcers and previous hearing or vision problems.
Drug Interactions
Sildenafil can interact with several medicines.
The supplied information specifically mentions:
- Nitrates: contraindicated because of the risk of severe hypotension.
- Alpha-blockers: may increase blood-pressure-lowering effects.
- Cimetidine: may affect sildenafil exposure.
- Ketoconazole and itraconazole: may increase sildenafil exposure.
- Erythromycin: may increase sildenafil exposure.
- Rifampicin: may alter sildenafil exposure.
- Ritonavir and saquinavir: may substantially affect sildenafil concentrations.
Patients should inform their doctor or pharmacist about all prescription medicines, over-the-counter medicines, vitamins and supplements they are using.
Alcohol
The supplied information advises caution with alcohol. Alcohol can itself temporarily impair erectile function, and substantial alcohol consumption may also contribute to dizziness or blood-pressure changes.
Patients should avoid excessive alcohol consumption when using sildenafil.
Common Adverse Reactions
The supplied information reports several possible adverse effects, including:
- Headache
- Dizziness
- Flushing
- Indigestion
- Nasal congestion
- Diarrhoea
- Rash
Other reported effects include unusual heartbeat, urinary tract symptoms, blood in the urine, persistent headache, fainting and nosebleeds.
Serious Adverse Reactions
Some symptoms require urgent medical attention.
These include:
- Chest pain
- Sudden decrease or loss of hearing
- Sudden loss or significant change in vision
- Seizures or convulsions
- Severe allergic reactions
- An erection lasting more than four hours
A prolonged erection, particularly one lasting more than four hours, can cause permanent tissue damage and requires emergency medical treatment.
Sudden visual or hearing changes should also be treated as urgent medical problems.
Vision and Hearing Precautions
The supplied information specifically warns about sudden loss of vision and hearing.
Patients who experience sudden visual loss, blurred vision, changes in colour perception or unusual sensitivity to light should stop treatment and seek urgent medical assessment.
Likewise, sudden reduction or loss of hearing requires prompt medical evaluation.
Pregnancy and Female Use
The supplied source identifies ViagrON as a treatment for erectile dysfunction in men and states that it is not for use in women.
The product should therefore not be presented as a general sexual-health medicine for female use.
Product Quality and Packaging
Patients should check the packaging before use. The supplied information advises against using the product when the packaging is torn, damaged, appears tampered with or otherwise does not look correct.
Expired products should not be used.
Regulatory and Pharmaceutical Information
The supplied information identifies ViagrON as a prescription product from Hilma Biocare. However, no independent regulatory documentation for the specific ViagrON 100 presentation has been provided.
Accordingly, the product should not be described as EU-authorised, officially equivalent to a particular branded product, or legally saleable throughout Europe without appropriate national regulatory verification.
Important Pharmaceutical Disclaimer
ViagrON 100 contains a pharmacologically active PDE-5 inhibitor. This product information is based on the supplied source material and does not replace official prescribing information or professional medical advice.
Patients should consult a qualified healthcare professional before using sildenafil, particularly if they have cardiovascular disease, liver or kidney impairment, blood-pressure problems, visual or hearing disorders, or take nitrate medicines or other medicines that may interact with sildenafil.
Presentation
ViagrON 100 mg tablets – 10 tablets.
Storage
Store in a cool, dry place below 30°C.
Protect from direct sunlight.
Keep out of reach of children.
